JP2017501978A5 - - Google Patents

Download PDF

Info

Publication number
JP2017501978A5
JP2017501978A5 JP2016533153A JP2016533153A JP2017501978A5 JP 2017501978 A5 JP2017501978 A5 JP 2017501978A5 JP 2016533153 A JP2016533153 A JP 2016533153A JP 2016533153 A JP2016533153 A JP 2016533153A JP 2017501978 A5 JP2017501978 A5 JP 2017501978A5
Authority
JP
Japan
Prior art keywords
amino
alkyl
optionally substituted
methyl
oxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016533153A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017501978A (ja
JP6496728B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2014/066608 external-priority patent/WO2015077451A1/en
Publication of JP2017501978A publication Critical patent/JP2017501978A/ja
Publication of JP2017501978A5 publication Critical patent/JP2017501978A5/ja
Application granted granted Critical
Publication of JP6496728B2 publication Critical patent/JP6496728B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016533153A 2013-11-21 2014-11-20 ホルミルペプチド受容体の調節因子としてのカルバミン酸フェニル誘導体 Expired - Fee Related JP6496728B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361907320P 2013-11-21 2013-11-21
US61/907,320 2013-11-21
PCT/US2014/066608 WO2015077451A1 (en) 2013-11-21 2014-11-20 Phenylcarbamate derivatives as formyl peptide receptor modulators

Publications (3)

Publication Number Publication Date
JP2017501978A JP2017501978A (ja) 2017-01-19
JP2017501978A5 true JP2017501978A5 (enExample) 2017-11-24
JP6496728B2 JP6496728B2 (ja) 2019-04-03

Family

ID=52101595

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016533153A Expired - Fee Related JP6496728B2 (ja) 2013-11-21 2014-11-20 ホルミルペプチド受容体の調節因子としてのカルバミン酸フェニル誘導体

Country Status (10)

Country Link
US (1) US9926264B2 (enExample)
EP (1) EP3071548B1 (enExample)
JP (1) JP6496728B2 (enExample)
KR (1) KR102310615B1 (enExample)
CN (1) CN105705484B (enExample)
AU (1) AU2014352922B2 (enExample)
BR (1) BR112016011417A8 (enExample)
CA (1) CA2930084A1 (enExample)
RU (1) RU2703725C1 (enExample)
WO (1) WO2015077451A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT2770989T (pt) 2011-10-26 2018-12-04 Allergan Inc Derivados de amida de aminoácidos substituídos por n-ureia como moduladores de recetor tipo-1 do recetor de péptidos formil (fprl-1)
CA2899804A1 (en) 2013-03-06 2014-09-12 Allergan, Inc. Use of agonists of formyl peptide receptor 2 for treating dermatological diseases
US9663457B2 (en) 2014-04-09 2017-05-30 Allergan, Inc. Carbamoyl hydrazine derivatives as formyl peptide modulators
US10301269B2 (en) 2014-05-21 2019-05-28 Allergan, Inc. Imidazole derivatives as formyl peptide receptor modulators
GB201712282D0 (en) * 2017-07-31 2017-09-13 Nodthera Ltd Selective inhibitors of NLRP3 inflammasome

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05163221A (ja) * 1991-12-17 1993-06-29 Fujirebio Inc オキシ酸誘導体
IL148426A0 (en) * 1999-08-27 2002-09-12 Cytovia Inc α-HYDROXY ACID DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
CN100506802C (zh) * 2004-06-04 2009-07-01 中国科学院上海药物研究所 一类甲酰肽样受体-1调节剂、其制备方法和用途
KR101724765B1 (ko) * 2009-05-18 2017-04-07 액테리온 파마슈티칼 리미티드 Alx 수용체 및/또는 fprl2 아고니스트로서의 브릿지 스피로[2.4]헵탄 유도체
CA2819457A1 (en) 2010-12-03 2012-06-07 Allergan, Inc. Pharmaceutical compositions comprising 3,4-dihydroisoquinolin-2(1h)-yl-3-phenylurea derivatives having formyl peptide receptor like-1 (fprl-1) agonist or antagonist activity
WO2012109544A1 (en) 2011-02-11 2012-08-16 Allergan, Inc. Novel 1-(1-oxo-1,2,3,4-tetrahydroisoquinolin-7-yl)urea derivatives as n-formyl peptide receptor like-1 (fprl-1) receptor modulators
PT2770989T (pt) * 2011-10-26 2018-12-04 Allergan Inc Derivados de amida de aminoácidos substituídos por n-ureia como moduladores de recetor tipo-1 do recetor de péptidos formil (fprl-1)
US8541577B2 (en) 2011-11-10 2013-09-24 Allergan, Inc. Aryl urea derivatives as N-formyl peptide receptors like-1 (FPRL-1) receptor modulators
US8492556B2 (en) 2011-11-10 2013-07-23 Allergan, Inc. 2,5-Dioxoimidazolidin-1-yl-3-phenylurea derivatives as formyl peptide receptor like-1 (FPRL-1) receptor modulators
CA2864893A1 (en) 2012-02-16 2013-08-22 Allergan, Inc. Imidazolidine-2,4-dione derivatives as n-formyl peptide receptor 2 modulators
WO2013158597A1 (en) 2012-04-16 2013-10-24 Allergan, Inc. (2-ureidoacetamido)alkyl derivatives as formyl peptide receptor 2 modulators
AU2014290618B2 (en) 2013-07-16 2018-04-05 Allergan, Inc. Derivatives of N-urea substituted amino acids as formyl peptide receptor modulators
US9920013B2 (en) 2014-01-29 2018-03-20 Allergan, Inc. 2,5-dioxoimidazolidin-1-yl-3-urea derivatives as formyl peptide modulators
US9604934B2 (en) 2014-01-29 2017-03-28 Allergan, Inc. Urea hydantoin derivatives as formyl peptide modulators
US9663457B2 (en) 2014-04-09 2017-05-30 Allergan, Inc. Carbamoyl hydrazine derivatives as formyl peptide modulators
US10301269B2 (en) 2014-05-21 2019-05-28 Allergan, Inc. Imidazole derivatives as formyl peptide receptor modulators

Similar Documents

Publication Publication Date Title
RU2017129434A (ru) Амидные производные n-карбамид-замещенных аминокислот как модуляторы формилпептидного рецептора-1 (fprl-1)
JP2016529235A5 (enExample)
JP2015520130A5 (enExample)
JP2024543975A5 (enExample)
RU2016119347A (ru) Производные фенилкарбамата в качестве модуляторов формилпептидного рецептора
ES2232114T3 (es) Derivados de cicloalqueno, procedimiento para su produccion, y uso.
JP2014525426A5 (enExample)
NZ610230A (en) Compositions and methods for treating ocular edema, neovascularization and related diseases
JP2019505541A5 (enExample)
RU2013132650A (ru) Серные производные в качестве модуляторов хемокиновых рецепторов
RU2013150332A (ru) Замещенные бициклические метиламинные производные как модуляторы рецепторов сфингозин-1-фосфата
NZ603198A (en) Novel hydroxamic acid derivative
JP2009542815A5 (enExample)
JP2014502979A5 (enExample)
JP2016512193A5 (enExample)
EA201591775A1 (ru) Замещенные ароматические соединения и связанный с ними способ лечения фиброза
JP2015526487A5 (enExample)
KR20140145203A (ko) 포르밀 펩타이드 수용체 2 조절물질로서 (2-우레이도아세트아미도)알킬 유도체
JP2014533274A5 (enExample)
RU2016145596A (ru) Производные имидазола как модуляторы формилпептидного рецептора
JP2017520528A5 (enExample)
JP2017537937A5 (enExample)
WO2013057251A3 (en) Heteroaryl hydroxamic acid derivatives and their use in the treatment, amelioration or prevention of a viral disease
JP2018532692A (ja) ホルミルペプチド受容体1(fpr1)選択的アゴニストとしてのフェニル尿素類似体
HRP20170045T1 (hr) Difluorlaktamski spojevi kao selektivni agonisti ep4 receptora za uporabu za liječenje bolesti i stanja posredovanih s ep4 receptorom